Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Studies on sublingual formulations are still limited, so outcomes may differ from tirzepatide injections
In addition, there was no significant linear relationship between dose (g/day) (coefficients = 0.02, p = 0.600) and duration of intervention (weeks) (coefficients = 0.54, p = 0.578) and changes in insulin (Figures 6B, 7B)
Learn more Everything you need to know
Beinaglutide is another short-acting recombinant human GLP-1RA that closely resembles human GLP-1(6-37), approved in China for the indications of type 2 diabetes mellitus and weight loss
Use it once or twice a day, depending on the product's directions
US$ 27.56
US$ 21.79
US$ 23.71
